Solid Tumors
Showing 26 - 50 of 598
CIBMTR Research Database
Recruiting
- Autologous Stem Cell Transplantation
- +6 more
-
Minneapolis, Minnesota
- +1 more
Jan 20, 2023
Solid Tumors Trial run by the National Cancer Institute (NCI) (Bevacizumab, Dasatinib)
Completed
- Solid Tumors
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 19, 2023
Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Neuroblastoma Trial in Worldwide (Idasanutlin, Venetoclax,
Recruiting
- Acute Myeloid Leukemia (AML)
- +3 more
- Idasanutlin
- +6 more
-
Phoenix, Arizona
- +19 more
Jan 18, 2023
Solid Tumors Trial in Worldwide (Screening platform)
Recruiting
- Solid Tumors
- Screening platform
-
Tucson, Arizona
- +50 more
Jan 18, 2023
Solid Tumors, Primary Brain Tumors Trial in United States (Vincristine, Irinotecan, Temozolomide)
Completed
- Solid Tumors
- Primary Brain Tumors
- Vincristine
- +3 more
-
Hartford, Connecticut
- +13 more
Jan 12, 2023
Advanced Malignancies, NSCLC, Ovarian Cancer Trial in Worldwide (Avelumab, Lorlatanib, Talazoparib)
Recruiting
- Advanced Malignancies
- +4 more
- Avelumab
- +7 more
-
Fayetteville, Arkansas
- +61 more
Jan 10, 2023
Lung Cancer Squamous Cell, Solid Tumors, Head & Neck Cancer Trial in Boston (Palbociclib, Gedatolisib)
Recruiting
- Lung Cancer Squamous Cell
- +3 more
-
Boston, Massachusetts
- +2 more
Jan 9, 2023
Solid Tumors Trial in Shanghai City (Ipatasertib)
Active, not recruiting
- Solid Tumors
-
Shanghai City, ChinaFudan University Shanghai Cancer Center
Jan 8, 2023
Solid Tumors Trial in Budapest ([¹4C]-BI 907828 mixed with BI 907828 (formulation 1), [¹4C]-BI 907828 mixed with BI 907828
Recruiting
- Solid Tumors
- [¹⁴C]-BI 907828 mixed with BI 907828 (formulation 1)
- +2 more
-
Budapest, HungaryPRA Hungary Ltd.
Jan 9, 2023
Metastatic Cancer, Solid Tumors, Advanced Cancer Trial in United States (ASP9801, Pembrolizumab)
Recruiting
- Metastatic Cancer
- +2 more
- ASP9801
- Pembrolizumab
-
Birmingham, Alabama
- +26 more
Jan 6, 2023
Ovarian Cancer, Cervical Cancer, Endometrial Cancer Trial in Worldwide (Enapotamab vedotin (HuMax-AXL-ADC))
Completed
- Ovarian Cancer
- +7 more
- Enapotamab vedotin (HuMax-AXL-ADC)
-
Phoenix, Arizona
- +40 more
Dec 12, 2022
Genomic Profiling in Cancer Patients
Recruiting
- Solid Tumors
- Hematologic Cancers
- molecular profiling of tumors
- Clinical Germline Analysis
-
Bridgeport, Connecticut
- +17 more
Dec 28, 2022
Biliary Tract Cancer (BTC), Colorectal Cancer (CRC), Endometrial Cancer Trial in Belgium, United Kingdom, United States
Completed
- Biliary Tract Cancer (BTC)
- +5 more
- INCB001158
- +6 more
-
Birmingham, Alabama
- +9 more
Dec 22, 2022
Advanced Cancers, Solid Tumors Trial in Houston (Pazopanib, Everolimus)
Active, not recruiting
- Advanced Cancers
- Solid Tumors
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 16, 2022
Solid Tumors Trial (TCR-T cells, Fludarabine, Cyclophosphamide Capsules)
Not yet recruiting
- Solid Tumors
- TCR-T cells
- +4 more
- (no location specified)
Dec 12, 2022